We identified patients from four institutions who underwent PSMA PET/CT scans pretreatment for primary staging or postradical prostatectomy (RP) for suspected recurrence and had Decipher ...

Firmonertinib combined with platinum-based chemotherapy in patients with EGFR-mutant advanced NSCLC following disease progression on first-line third-generation EGFR-TKI. This is an ASCO Meeting ...